Cost–effectiveness analysis of influenza vaccination for people aged 65 and over in Japan

Cost-effectiveness analysis of influenza and pneumococcal vaccination for Hong Kong elderly in long-term care facilities

“…The NPV (US$334) of influenza vaccine in the present study was consistent with findings in the literature that the influenza vaccine was cost-saving among elderly people at higher risk, such as patients with chronic illnesses, than no vaccination 2 3 23 24 25 26 27 28. A study conducted among elderly patients in Minnesota showed that influenza vaccination was associated with net savings of US$73 per patient vaccinated 29.…”

Cost-effectiveness analysis of quadrivalent versus trivalent influenza vaccine in Taiwan: A lifetime multi-cohort model

“…12,13 However, when analyzing the cost-effectiveness of QIV, it should be compared with current vaccination program instead of no intervention. This study used a lifetime, multi-cohort Markov model to compare the impact of QIV and TIV on the disease burden of influenza in Taiwan from the governmental perspective.…”

Economic value of influenza vaccination

“…Age-based immunization programs are targeted to persons over 60, 65 or 70 y old, while risk-based immunization ones to those with preexisting diseases. 2,4 Providing indirect protection through the vaccination of other population subgroups could be a complementary approach. In fact, vaccination of children as well as of healthcare workers has been showed to produce indirect benefits to the community by reducing mortality and morbidity in other vulnerable categories.…”